Your session is about to expire
← Back to Search
Study Summary
This trial will test whether a single injection of SI-6603 into the discs of people with lumbar disc herniation is effective.
- Slipped Disc
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other studies has SI-6603 been involved in?
"As of now, there is only 1 clinical trial underway for SI-6603. That 1 trial is currently in Phase 3. Even though most studies for SI-6603 are conducted in Sheffield, Alabama, there are a total of 93 locations running trials for this medication."
Are new patients being registered for this experiment?
"The clinical trial, which was originally posted on May 30th, 2018, is not currently seeking patients according to information on clinicaltrials.gov. Although this study is not looking for candidates, there are 203 other studies that are."
Do we have a solid presence of this trial in Canada?
"There are a total of 61 running clinical trials for this study. These trials are being conducted at locations like the Clinical Inquest Center Ltd in Beavercreek, St. Louis Pain Consultants in Chesterfield, Tulane University School of Medicine in New Orleans, and 58 other sites."
Does this type of research exist?
"As of now, only one trial for SI-6603 is ongoing, covering 85 cities in a single nation. The first trial for SI-6603 occurred in 2018. That year, Seikagaku Corporation ran the 320-person Phase 3 clinical trial which completed the drug approval process. In the years since 2018, 39 more trials have taken place."
Can middle-aged individuals participate in this research?
"Eligibility requirements for this particular trial state that patients must be between 30 and 70 years old. If the patient does not meet this age requirement, there are 16 other trials that might be a better fit. If the patient is over 65, there are 172 other potential trials."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger